Cite
MLA Citation
Vladislav Berdunov et al.. “Combined cost-utility analysis of the 21-gene assay to guide chemotherapy in HR+/HER2- breast cancer.” European journal of surgical oncology, vol. 49, no. 5, 2023, pp. e236–. http://access.bl.uk/ark:/81055/vdc_100184744276.0x000030